These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 15294262)

  • 41. Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicentre, randomized, double-blind, placebo-controlled study.
    Bianconi L; Castro A; Dinelli M; Alboni P; Pappalardo A; Richiardi E; Santini M
    Eur Heart J; 2000 Aug; 21(15):1265-73. PubMed ID: 10924317
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The pharmacological response of ischemia-related atrial fibrillation in dogs: evidence for substrate-specific efficacy.
    Rivard L; Sinno H; Shiroshita-Takeshita A; Schram G; Leung TK; Nattel S
    Cardiovasc Res; 2007 Apr; 74(1):104-13. PubMed ID: 17316585
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model.
    Ashikaga K; Kobayashi T; Kimura M; Owada S; Sasaki S; Iwasa A; Furukawa K; Motomura S; Okumura K
    Eur J Pharmacol; 2006 Apr; 536(1-2):148-53. PubMed ID: 16556442
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential ionic mechanism for repolarization differences between canine right and left atrium.
    Li D; Zhang L; Kneller J; Nattel S
    Circ Res; 2001 Jun; 88(11):1168-75. PubMed ID: 11397783
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium: insights into the mechanism of the superior efficacy of amiodarone.
    Shinagawa K; Shiroshita-Takeshita A; Schram G; Nattel S
    Circulation; 2003 Mar; 107(10):1440-6. PubMed ID: 12642367
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antiarrhythmic effect of the Ca
    Kirchhoff JE; Diness JG; Abildgaard L; Sheykhzade M; Grunnet M; Jespersen T
    Pflugers Arch; 2016 Nov; 468(11-12):1853-1863. PubMed ID: 27722784
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential effects of dofetilide, amiodarone, and class lc drugs on left and right atrial refractoriness and left atrial vulnerability in pigs.
    Wirth KJ; Knobloch K
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):166-74. PubMed ID: 11218069
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Magnitude of increase in QTc interval after initiation of dofetilide in patients with persistent atrial fibrillation is associated with increased rates of pharmacological cardioversion and long-term freedom from recurrent atrial fibrillation.
    Huang HD; Waks JW; Steinhaus DA; Zimetbaum P
    Heart Rhythm; 2016 Jul; 13(7):1410-7. PubMed ID: 26921760
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness.
    Wang J; Bourne GW; Wang Z; Villemaire C; Talajic M; Nattel S
    Circulation; 1993 Sep; 88(3):1030-44. PubMed ID: 8353865
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation.
    Kirchhof P; Engelen M; Franz MR; Ribbing M; Wasmer K; Breithardt G; Haverkamp W; Eckardt L
    Basic Res Cardiol; 2005 Mar; 100(2):112-21. PubMed ID: 15696400
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Electrophysiological characterization and antiarrhythmic efficacy of the mixed potassium channel-blocking antiarrhythmic agent AZ13395438 in vitro and in vivo.
    Jacobson I; Duker G; Florentzson M; Linhardt G; Lindhardt E; Nordkam AK; Åstrand A; Carlsson L
    J Cardiovasc Pharmacol Ther; 2013 May; 18(3):290-300. PubMed ID: 23307834
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Small Conductance Calcium-Activated Potassium Channel Inhibitors NS8593 and UCL1684 Prevent the Development of Atrial Fibrillation Through Atrial-Selective Inhibition of Sodium Channel Activity.
    Burashnikov A; Barajas-Martinez H; Hu D; Robinson VM; Grunnet M; Antzelevitch C
    J Cardiovasc Pharmacol; 2020 Aug; 76(2):164-172. PubMed ID: 32453071
    [TBL] [Abstract][Full Text] [Related]  

  • 53. AZD1305 exerts atrial predominant electrophysiological actions and is effective in suppressing atrial fibrillation and preventing its reinduction in the dog.
    Burashnikov A; Zygmunt AC; Di Diego JM; Linhardt G; Carlsson L; Antzelevitch C
    J Cardiovasc Pharmacol; 2010 Jul; 56(1):80-90. PubMed ID: 20386458
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Electrophysiologic Effects of the New Class III Antiarrhythmic Drug Dofetilide in an Experimental Canine Model of Pacing-induced Atrial Fibrillation.
    Feld GK; Cha Y
    J Cardiovasc Pharmacol Ther; 1997 Jul; 2(3):195-203. PubMed ID: 10684458
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Can inhibition of IKur promote atrial fibrillation?
    Burashnikov A; Antzelevitch C
    Heart Rhythm; 2008 Sep; 5(9):1304-9. PubMed ID: 18774108
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of dofetilide and ranolazine on atrial fibrillatory rate in a horse model of acutely induced atrial fibrillation.
    Carstensen H; Hesselkilde EZ; Haugaard MM; Flethøj M; Carlson J; Pehrson S; Jespersen T; Platonov PG; Buhl R
    J Cardiovasc Electrophysiol; 2019 Apr; 30(4):596-606. PubMed ID: 30661267
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MS-551 and KCB-328, two class III drugs aggravated adrenaline-induced arrhythmias.
    Xue Y; Yamada C; Aye NN; Hashimoto K
    Br J Pharmacol; 1998 Aug; 124(8):1712-8. PubMed ID: 9756388
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coronary artery disease potentiates response to dofetilide for rhythm control of atrial fibrillation.
    Manocha P; Bavikati V; Langberg J; Lloyd MS
    Pacing Clin Electrophysiol; 2012 Feb; 35(2):170-3. PubMed ID: 22017595
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiovascular drugs. Dofetilide.
    Mounsey JP; DiMarco JP
    Circulation; 2000 Nov; 102(21):2665-70. PubMed ID: 11085972
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparison of the rate dependent effects of dofetilide and ibutilide in the newborn heart.
    Pickoff AS; Stolfi A
    Pacing Clin Electrophysiol; 2001 May; 24(5):816-23. PubMed ID: 11388101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.